Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 8,629 | 0 | 0 | 0 | 0 |
| Gross Profit | 8,629 | N/A | N/A | N/A | N/A |
| Operating Expenses | 48,482 | 101,622 | 2,294 | 1,991 | 345 |
| Operating Income | -39,853 | 1,072 | -2,294 | -1,991 | -345 |
| Other Income | -2,165 | -19,138 | -2,487 | 818 | 1,729 |
| Pre-tax Income | -42,018 | -18,066 | -4,780 | -1,173 | 1,385 |
| Net Income Continuous | -42,018 | -18,066 | -4,780 | -1,173 | 1,385 |
| Net Income | $-42,018 | $-18,066 | $-4,780 | $-1,173 | $1,385 |
| EPS Basic Total Ops | -0.51 | -0.93 | -0.27 | -0.07 | 0.08 |
| EPS Basic Continuous Ops | -0.51 | 0.13 | -1.39 | -0.34 | 0.40 |
| EPS Diluted Total Ops | -0.51 | -0.93 | -0.27 | -0.07 | 0.08 |
| EPS Diluted Continuous Ops | -0.51 | 0.13 | -1.39 | -0.34 | 0.40 |
| EBITDA(a) | $-39,844 | $-101,622 | $-2,294 | $-1,991 | $-345 |